Barclays »

Conmed Corp Note 2.250 6/1 shares owned by Barclays

Quarter-by-quarter ownership of Conmed Corp Note 2.250 6/1 shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Conmed Corp Note 2.250 6/1

Tip: Access up to 7 years of quarterly data

All positions including Conmed Corp Note 2.250 6/1 held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Conmed Corp Note 2.250 6/1 by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.6M 3.6M 1.00
2023-09-30 $3.2M 3.4M 0.95
2023-06-30 $2.2M 1.9M 1.12

More positions owned by Barclays

Invesco Qqq Tr Opt Call Option (QQQ)
SPDR S&ampP 500 ETF TR Opt Put Option (SPY)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple (AAPL)
Amazon Opt Call Option (AMZN)
Alphabet Opt Put Option (GOOGL)
NVIDIA Corporation (NVDA)
Tesla Opt Put Option (TSLA)
Meta Platforms Opt Put Option (META)
Ishares Tr Fund (HYG)
Alphabet Opt Call Option (GOOG)
Visa Opt Put Option (V)
Broadcom (AVGO)
Berkshire Hathaway (BRK.B)

View all positions for Barclays

Top funds holding Conmed Corp Note 2.250 6/1

Wolverine Asset Management
Calamos Advisors
MacKay Shields
Millennium Management
Highbridge Capital Management
Citadel Advisors
Lazard Asset Management
III Capital Management
Segantii Capital Management
CSS
Shenkman Capital Management
Zazove Associates
Wells Fargo & Company
Absolute Investment Advisers
Bnp Paribas Arbitrage, Snc

View all funds holding Conmed Corp Note 2.250 6/1